Imaging Macrophage and Hematopoietic Progenitor Proliferation in Atherosclerosis.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 26394773)

Published in Circ Res on September 22, 2015

Authors

Yu-Xiang Ye1, Claudia Calcagno1, Tina Binderup1, Gabriel Courties1, Edmund J Keliher1, Gregory R Wojtkiewicz1, Yoshiko Iwamoto1, Jun Tang1, Carlos Pérez-Medina1, Venkatesh Mani1, Seigo Ishino1, Camilla Bardram Johnbeck1, Ulrich Knigge1, Zahi A Fayad1, Peter Libby1, Ralph Weissleder1, Ahmed Tawakol1, Shipra Dubey1, Anthony P Belanger1, Marcelo F Di Carli1, Filip K Swirski1, Andreas Kjaer1, Willem J M Mulder1, Matthias Nahrendorf2

Author Affiliations

1: From the Center for Systems Biology, Department of Radiology (Y.-X.Y., G.C., E.J.K., G.R.W., Y.I., R.W., F.K.S., M.N.) and Division of Cardiology (A.T.), Massachusetts General Hospital and Harvard Medical School, Boston; Translational and Molecular Imaging Institute, Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY (C.C., J.T., C.P.-M., V.M., S.I., Z.A.F., W.J.M.M.); Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging (T.B., C.B.J., A.K.) and Departments of Clinical Endocrinology PE and Surgery C (U.K.), Rigshospitalet, National University Hospital & University of Copenhagen, Copenhagen, Denmark; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA (P.L., M.F.D.C.); Department of Systems Biology, Harvard Medical School, Boston, MA (R.W.); Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (S.D., A.P.B., M.F.D.C.); and Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands (W.J.M.M.).
2: From the Center for Systems Biology, Department of Radiology (Y.-X.Y., G.C., E.J.K., G.R.W., Y.I., R.W., F.K.S., M.N.) and Division of Cardiology (A.T.), Massachusetts General Hospital and Harvard Medical School, Boston; Translational and Molecular Imaging Institute, Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY (C.C., J.T., C.P.-M., V.M., S.I., Z.A.F., W.J.M.M.); Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging (T.B., C.B.J., A.K.) and Departments of Clinical Endocrinology PE and Surgery C (U.K.), Rigshospitalet, National University Hospital & University of Copenhagen, Copenhagen, Denmark; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA (P.L., M.F.D.C.); Department of Systems Biology, Harvard Medical School, Boston, MA (R.W.); Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (S.D., A.P.B., M.F.D.C.); and Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands (W.J.M.M.). mnahrendorf@mgh.harvard.edu.

Articles cited by this

Inflammation in atherosclerosis. Nature (2002) 28.92

Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J Clin Invest (2007) 8.65

Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment. Immunity (2006) 5.98

Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. Nat Med (1998) 5.14

ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation. Science (2010) 4.67

Myocardial infarction accelerates atherosclerosis. Nature (2012) 4.48

Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat Med (2013) 4.14

Tissue-resident macrophages. Nat Immunol (2013) 4.09

In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol (2006) 3.91

Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science (2013) 3.22

Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography. J Nucl Cardiol (2005) 2.65

3'-deoxy-3'-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography. Cancer Res (2003) 2.46

Extramedullary hematopoiesis generates Ly-6C(high) monocytes that infiltrate atherosclerotic lesions. Circulation (2011) 2.45

18F-FLT PET in hematologic disorders: a novel technique to analyze the bone marrow compartment. J Nucl Med (2006) 2.18

Splenic metabolic activity predicts risk of future cardiovascular events: demonstration of a cardiosplenic axis in humans. JACC Cardiovasc Imaging (2015) 2.02

Imaging of cell proliferation: status and prospects. J Nucl Med (2008) 2.02

Detection of neovessels in atherosclerotic plaques of rabbits using dynamic contrast enhanced MRI and 18F-FDG PET. Arterioscler Thromb Vasc Biol (2008) 1.73

Monocyte and macrophage heterogeneity in the heart. Circ Res (2013) 1.63

Correlation between Ki-67 immunohistochemistry and 18F-fluorothymidine uptake in patients with cancer: A systematic review and meta-analysis. Eur J Cancer (2012) 1.41

[(18)F]FLT-PET imaging does not always "light up" proliferating tumor cells. Clin Cancer Res (2011) 1.35

Imaging and nanomedicine in inflammatory atherosclerosis. Sci Transl Med (2014) 1.23

Limits of [18F]-FLT PET as a biomarker of proliferation in oncology. PLoS One (2013) 1.12

Macrophages retain hematopoietic stem cells in the spleen via VCAM-1. J Exp Med (2015) 1.06

Ischemic stroke activates hematopoietic bone marrow stem cells. Circ Res (2014) 1.00

Spatial mapping of functional pelvic bone marrow using FLT PET. J Appl Clin Med Phys (2014) 0.90